Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6026
Peer-review started: October 26, 2014
First decision: November 14, 2014
Revised: November 26, 2014
Accepted: December 16, 2014
Article in press: December 16, 2014
Published online: May 21, 2015
Processing time: 208 Days and 19.3 Hours
AIM: To provide a quantitative assessment of the association between type 2 diabetes mellitus (T2DM) and the risk of colorectal cancer (CRC).
METHODS: Systematic review was conducted thorough MEDLINE, EMBASE, Cochrane Library, and ISI Web of knowledge databases till 31st January 2014. This meta-analysis included the cohort studies that illustrated relative risk (RR) or odds ratio estimates with 95%CI for the predictive risk of CRC by T2DM. Summary relative risks with 95%CI were analyzed by using an effects summary ratio model. Heterogeneity among studies was assessed by the Cochran’s Q and I2 statistics.
RESULTS: The meta analysis of 8 finally selected studies showed a positive correlation of T2DM with the risk of CRC as depicted by effects summary RR of 1.21 (95%CI: 1.02-1.42). Diabetic women showed greater risk of developing CRC as their effect summary RR of 1.22 (95%CI: 1.01-49) with significant overall Z test at 5% level of significance was higher than the effect summary RR of 1.17 (95%CI: 1.00-1.37) of men showing insignificant Z test. The effect summary RR of 1.19 with 95%CI of 1.07-1.33 indicate a positive relationship between DM and increased risk of CRC with significant heterogeneity (I2 = 92% and P-value < 0.05).
CONCLUSION: Results from this systematic review and meta-analysis report that diabetic people have an increased risk of CRC as compared to non-diabetics.
Core tip: The prevalence of diabetes for all age groups worldwide is estimated to be 2.8% in 2000 and 4.4% in 2030. Type 2 diabetes mellitus (T2DM) is associated with increased insulin resistance and insulin has been reported to exhibit procarcinogenic effects in a number of human systems including colon and rectum. This meta-analysis of 8 relevant cohort studies showed an increased risk for colorectal carcinoma by T2DM, and this association was more evident in diabetic women than men.